Skip to main content
Clinical Trials/NCT06276790
NCT06276790
Completed
N/A

The Predictive Value of an Ultrasound Quantitative Scoring System for Treatment Method Selection in Patients With Caesarean Scar Pregnancy: A Single-Centre Retrospective Study

Chengde Central Hospital1 site in 1 country117 target enrollmentJanuary 18, 2019

Overview

Phase
N/A
Intervention
Not specified
Conditions
Caesarean Scar Pregnancy
Sponsor
Chengde Central Hospital
Enrollment
117
Locations
1
Primary Endpoint
intraoperative blood loss
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

This study uses a systematic scoring method combined with clinical and ultrasound data to comprehensively evaluate patient conditions and explore the guiding value of the ultrasound quantitative scoring system for selecting the surgical approach for caesarean scar pregnancy.

Registry
clinicaltrials.gov
Start Date
January 18, 2019
End Date
December 25, 2022
Last Updated
2 years ago
Study Type
Observational
Sex
Female

Investigators

Sponsor
Chengde Central Hospital
Responsible Party
Principal Investigator
Principal Investigator

Jianwen Du

physician

Chengde Central Hospital

Eligibility Criteria

Inclusion Criteria

  • history of at least one previous caesarean section
  • symptoms suggestive of caesarean scar pregnancy, such as unexplained abnormal vaginal bleeding, abdominal pain, cervical pain or abnormal uterine activity during pregnancy
  • amenorrhea ≤84 days
  • ultrasound examination suggesting a single gestational sac with intact morphology
  • stable maternal vital signs

Exclusion Criteria

  • mass-type caesarean scar pregnancy
  • previous medication or surgical treatment before ultrasound examination
  • haemodynamically unstable patients
  • patients with surgical contraindications
  • incomplete or lost follow-up clinical data
  • patients with severe medical conditions such as hypertension, diabetes, hyperthyroidism and haemophilia

Outcomes

Primary Outcomes

intraoperative blood loss

Time Frame: during surgery

The patient's blood loss during surgery. Check the blood volume in ml of the aspirator reservoir.

serum β-HCG levels

Time Frame: Within 2 weeks after the operation

The time taken for serum β-HCG levels to return to normal

length of hospital stay

Time Frame: Within 1 week

Number of days the patient was hospitalized. Discharge assessment: vital signs stable, no abdominal pain, no active bleeding.

Study Sites (1)

Loading locations...

Similar Trials